{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:34:20Z","timestamp":1792762460176,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12868-015-0178-y","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T20:03:31Z","timestamp":1436558611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Differential effects of antidepressants escitalopram versus lithium on Gs alpha membrane relocalization"],"prefix":"10.1186","volume":"16","author":[{"given":"Robert J","family":"Donati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Schappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H","family":"Czysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M","family":"Rasenick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,11]]},"reference":[{"key":"178_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0024-3205(03)00249-2","volume":"73","author":"RJ Donati","year":"2003","unstructured":"Donati RJ, Rasenick MM (2003) G protein signaling and the molecular basis of antidepressant action. Life Sci 73:1\u201317","journal-title":"Life Sci"},{"key":"178_CR2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tips.2005.10.005","volume":"26","author":"JE Malberg","year":"2005","unstructured":"Malberg JE, Blendy JA (2005) Antidepressant action: to the nucleus and beyond. Trends Pharm Sci 26:631\u2013638","journal-title":"Trends Pharm Sci"},{"key":"178_CR3","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.neuroimage.2012.08.007","volume":"63","author":"P Zanotti-Fregonara","year":"2012","unstructured":"Zanotti-Fregonara P, Hines CS, Zoghbi SS, Liow JS, Zhang Y, Pike VW et al (2012) Innis RB population-based input function and image-derived input function for [(1)(1)C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorder. Neuroimage 63:1532\u20131541","journal-title":"Neuroimage"},{"key":"178_CR4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.npp.1300697","volume":"30","author":"RJ Donati","year":"2005","unstructured":"Donati RJ, Rasenick MM (2005) Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts). Neuropsychopharm 30:1238\u20131245","journal-title":"Neuropsychopharm"},{"key":"178_CR5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrn2059","volume":"8","author":"JA Allen","year":"2007","unstructured":"Allen JA, Halverson-Tamboli RA, Rasenick MM (2007) Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 8:128\u2013140","journal-title":"Nat Rev Neurosci"},{"key":"178_CR6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1124\/mol.109.060160","volume":"76","author":"JA Allen","year":"2009","unstructured":"Allen JA, Yu JZ, Dave RH, Bhatnagar A, Roth BL, Rasenick MM (2009) Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs\/adenylyl cyclase signaling. Mol Pharm 76:1082\u20131093","journal-title":"Mol Pharm"},{"key":"178_CR7","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1046\/j.1471-4159.1999.0731114.x","volume":"73","author":"S Toki","year":"1999","unstructured":"Toki S, Donati RJ, Rasenick MM (1999) Treatment of C6 glioma cells and rats with antidepressant drugs increases the detergent extraction of G(s alpha) from plasma membrane. J Neurochem 73:1114\u20131120","journal-title":"J Neurochem"},{"key":"178_CR8","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1523\/JNEUROSCI.5713-07.2008","volume":"28","author":"RJ Donati","year":"2008","unstructured":"Donati RJ, Dwivedi Y, Roberts RC, Conley RR, Pandey GN, Rasenick MM (2008) Postmortem brain tissue of depressed suicides reveals increased Gs alpha localization in lipid raft domains where it is less likely to activate adenylyl cyclase. J Neurosci 28:3042\u20133050","journal-title":"J Neurosci"},{"key":"178_CR9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.biopsych.2005.05.040","volume":"58","author":"LM Hines","year":"2005","unstructured":"Hines LM, Tabakoff B (2005) Platelet adenylyl cyclase activity: a biological marker for major depression and recent drug use. Biol Psych 58:955\u2013962","journal-title":"Biol Psych"},{"key":"178_CR10","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpsychires.2013.02.005","volume":"47","author":"JJ Mooney","year":"2013","unstructured":"Mooney JJ, Samson JA, McHale NL, Pappalarado KM, Alpert JE, Schildkraut JJ (2013) Increased Gsalpha within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study. J Psych Res 47:706\u2013711","journal-title":"J Psych Res"},{"key":"178_CR11","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1523\/JNEUROSCI.2460-05.2005","volume":"25","author":"B Eisensamer","year":"2005","unstructured":"Eisensamer B, Uhr M, Meyr S, Gimpl G, Deiml T, Rammes G et al (2005) Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains. J Neurosci 25:10198\u201310206","journal-title":"J Neurosci"},{"issue":"3","key":"178_CR12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/npp.2014.256","volume":"40","author":"AH Czysz","year":"2015","unstructured":"Czysz AH, Schappi JM, Rasenick MM (2015) Lateral diffusion of Galpha in the plasma membrane is decreased after chronic but not acute antidepressant treatment: role of lipid raft and non-raft membrane microdomains. Neuropsychopharm 40(3):766\u2013773","journal-title":"Neuropsychopharm"},{"key":"178_CR13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1399-5618.2009.00762.x","volume":"11","author":"L Mann","year":"2009","unstructured":"Mann L, Heldman E, Bersudsky Y, Vatner SF, Ishikawa Y, Almog O et al (2009) Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect. Bipolar Disord 11:885\u2013896","journal-title":"Bipolar Disord"},{"key":"178_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.mp.4000494","volume":"4","author":"RS Jope","year":"1999","unstructured":"Jope RS (1999) Anti-bipolar therapy: mechanism of action of lithium. Mol Psych 4:117\u2013128","journal-title":"Mol Psych"},{"key":"178_CR15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1017\/S1461145707008395","volume":"11","author":"L Mann","year":"2008","unstructured":"Mann L, Heldman E, Shaltiel G, Belmaker RH, Agam G (2008) Lithium preferentially inhibits adenylyl cyclase V and VII isoforms. Int J Neuropsychopharm 11:533\u2013539","journal-title":"Int J Neuropsychopharm"},{"key":"178_CR16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.pnpbp.2008.08.012","volume":"32","author":"F Marmol","year":"2008","unstructured":"Marmol F (2008) Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium. Prog Neuropsychopharmacol Biol Psych 32:1761\u20131771","journal-title":"Prog Neuropsychopharmacol Biol Psych"},{"issue":"Suppl 2","key":"178_CR17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1399-5618.2009.00714.x","volume":"11","author":"R Machado-Vieira","year":"2009","unstructured":"Machado-Vieira R, Manji HK, Zarate CA Jr (2009) The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11(Suppl 2):92\u2013109","journal-title":"Bipolar Disord"},{"key":"178_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","volume":"49","author":"JM Beaulieu","year":"2009","unstructured":"Beaulieu JM, Gainetdinov RR, Caron MG (2009) Akt\/GSK3 signaling in the action of psychotropic drugs. Ann Rev Pharm Tox 49:327\u2013347","journal-title":"Ann Rev Pharm Tox"},{"key":"178_CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1027355626355","volume":"22","author":"M Carli","year":"1997","unstructured":"Carli M, Afkhami-Dastjerdian S, Reader TA (1997) Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors. Neurochem Res 22:427\u2013435","journal-title":"Neurochem Res"},{"key":"178_CR20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000314310","volume":"62","author":"JA Quiroz","year":"2010","unstructured":"Quiroz JA, Machado-Vieira R, Zarate CA Jr, Manji HK (2010) Novel insights into lithium\u2019s mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiol 62:50\u201360","journal-title":"Neuropsychobiol"},{"key":"178_CR21","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/npp.2010.105","volume":"35","author":"X Li","year":"2010","unstructured":"Li X, Jope RS (2010) Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharm 35:2143\u20132154","journal-title":"Neuropsychopharm"},{"key":"178_CR22","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1073\/pnas.88.23.10634","volume":"88","author":"SF Colin","year":"1991","unstructured":"Colin SF, Chang HC, Mollner S, Pfeuffer T, Reed RR, Duman RS et al (1991) Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex. Proc Nat Acad Sci 88:10634\u201310637","journal-title":"Proc Nat Acad Sci"},{"key":"178_CR23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1124\/jpet.109.162644","volume":"332","author":"L Zhang","year":"2010","unstructured":"Zhang L, Rasenick MM (2010) Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound. J Pharm Exp Ther 332:977\u2013984","journal-title":"J Pharm Exp Ther"},{"key":"178_CR24","doi-asserted-by":"crossref","first-page":"15693","DOI":"10.1074\/jbc.270.26.15693","volume":"270","author":"S Li","year":"1995","unstructured":"Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH et al (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270:15693\u201315701","journal-title":"J Biol Chem"},{"key":"178_CR25","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1124\/mol.59.6.1426","volume":"59","author":"RJ Donati","year":"2001","unstructured":"Donati RJ, Thukral C, Rasenick MM (2001) Chronic treatment of C6 glioma cells with antidepressant drugs results in a redistribution of Gsalpha. Mol Pharm 59:1426\u20131432","journal-title":"Mol Pharm"},{"key":"178_CR26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jad.2011.12.041","volume":"137","author":"T Rivera-Baltanas","year":"2012","unstructured":"Rivera-Baltanas T, Olivares JM, Calado-Otero M, Kalynchuk LE, Martinez-Villamarin JR, Caruncho HJ (2012) Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder. J Affect Disord 137:46\u201355","journal-title":"J Affect Disord"},{"key":"178_CR27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/jama.290.11.1467","volume":"290","author":"FK Goodwin","year":"2003","unstructured":"Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 290:1467\u20131473","journal-title":"JAMA"},{"key":"178_CR28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1399-5618.2006.00344.x","volume":"8","author":"RJ Baldessarini","year":"2006","unstructured":"Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J (2006) Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 8:625\u2013639","journal-title":"Bipolar Disord"},{"key":"178_CR29","first-page":"834","volume":"1","author":"T Dousa","year":"1970","unstructured":"Dousa T, Hechter O (1970) Lithium and brain adenyl cyclase. Lancet 1:834\u2013835","journal-title":"Lancet"},{"key":"178_CR30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/259411a0","volume":"259","author":"R Ebstein","year":"1976","unstructured":"Ebstein R, Belmaker R, Grunhaus L, Rimon R (1976) Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans. Nature 259:411\u2013413","journal-title":"Nature"},{"key":"178_CR31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-3565(25)32037-9","volume":"213","author":"RP Ebstein","year":"1980","unstructured":"Ebstein RP, Hermoni M, Belmaker RH (1980) The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. J Pharm Exp Ther 213:161\u2013167","journal-title":"J Pharm Exp Ther"},{"key":"178_CR32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0028-3908(89)90108-1","volume":"28","author":"A Mork","year":"1989","unstructured":"Mork A, Geisler A (1989) The effects of lithium in vitro and ex vivo on adenylate cyclase in brain are exerted by distinct mechanisms. Neuropharm 28:307\u2013311","journal-title":"Neuropharm"},{"key":"178_CR33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.mp.4000444","volume":"4","author":"RS Jope","year":"1999","unstructured":"Jope RS (1999) A bimodal model of the mechanism of action of lithium. Mol Psych 4:21\u201325","journal-title":"Mol Psych"},{"issue":"Suppl 1","key":"178_CR34","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1038\/sj.mp.4001017","volume":"7","author":"RS Jope","year":"2002","unstructured":"Jope RS, Bijur GN (2002) Mood stabilizers, glycogen synthase kinase-3beta and cell survival. Mol Psych 7(Suppl 1):S35\u2013S45","journal-title":"Mol Psych"},{"key":"178_CR35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.npp.1300283","volume":"29","author":"TD Gould","year":"2004","unstructured":"Gould TD, Chen G, Manji HK (2004) In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharm 29:32\u201338","journal-title":"Neuropsychopharm"},{"key":"178_CR36","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1073\/pnas.1316425111","volume":"111","author":"I Farhy Tselnicker","year":"2014","unstructured":"Farhy Tselnicker I, Tsemakhovich V, Rishal I, Kahanovitch U, Dessauer CW, Dascal N (2014) Dual regulation of G proteins and the G-protein-activated K+ channels by lithium. Proc Nat Acad Sci 111:5018\u20135023","journal-title":"Proc Nat Acad Sci"},{"key":"178_CR37","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1471-4159.1995.64020724.x","volume":"64","author":"J Chen","year":"1995","unstructured":"Chen J, Rasenick MM (1995) Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase. J Neurochem 64:724\u2013732","journal-title":"J Neurochem"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-015-0178-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T03:53:47Z","timestamp":1748490827000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2202\/16\/40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1186\/s12868-015-0178-y","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,11]]},"article-number":"40"}}